Want to join the conversation?
Services and document technology provider, $XRX reported 3Q15 total GAAP revenue of $4,333MM, a decline of 10% YoverY. On an adjusted basis, excluding the HE charge, total revenues declined 7%, with a 3 percentage point negative impact from currency. GAAP net loss attributable to Xerox was $34MM or $0.04 per diluted share, down 75% from 3Q14.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.